Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Toralf Reimer

8PUBLICATIONS

105CO-AUTHORS

Predictive and prognostic markersCancer geneticsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jan 21, 2026

Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study.

Maggie Banys-Paluchowski, Steffi Hartmann, Jana de Boniface

|Sep 02, 2025

Reply to: Germline and Somatic <i>BRCA1/2</i> Mutations in Breast Cancer Treatment Strategies.

Eric Hahnen, Jan Hauke, Karen Gelmon

|Apr 10, 2025

<i>BRCA1/2</i> and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis.

Eric Hahnen, Jan Hauke, Karen Gelmon

|Oct 16, 2024

Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15).

Natalia Krawczyk, Thorsten Kühn, Nina Ditsch

|Nov 28, 2022

Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial.

Monika Graeser, Oleg Gluz, Claudia Biehl

|May 28, 2022

Radiological Underestimation of Tumor Size as a Relevant Risk Factor for Positive Margin Rate in Breast-Conserving Therapy of Pure Ductal Carcinoma In Situ (DCIS).

Gesche Schultek, Bernd Gerber, Toralf Reimer

Pageof 2

Frequent Collaborators

4 joint publications

Michael Untch

3 joint publications

Sibylle Loibl

3 joint publications

Frederik Marmé

3 joint publications

Miguel Martin

3 joint publications

Sung-Bae Kim

3 joint publications

Masakazu Toi

3 joint publications

Hope S Rugo

3 joint publications

Carsten Denkert

3 joint publications

Valentina Nekljudova

2 joint publications

Sherko Kuemmel

Frequent Collaborators

4 joint publications

Michael Untch

3 joint publications

Sibylle Loibl

3 joint publications

Frederik Marmé

3 joint publications

Miguel Martin

Top Related Videos

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin

Published on : Dec 16, 2013

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on : Feb 17, 2011

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on : Aug 12, 2015

See more related videos

Top Related Videos

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin

Generation of Lymph Node-fat Pad Chimeras for the Study of Lymph Node Stromal Cell Origin

Published on : Dec 16, 2013

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on : Feb 17, 2011

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Silencing of <em>BRCA2</em> to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on : Aug 12, 2015

See more related videos